Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000774·Cytek Biosciences, Inc.
Schedule 13G ownership disclosure
Cytek Biosciences Inc
Common Stock · CUSIP: 23285D109
Event date: 2025-06-30
- Filing-level shares
- 7,765,138
- Percent of class
- 6.13%
- The Vanguard Group
Shares: 7,765,138 · Class: 6.13%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000774
- Form type
- SCHEDULE 13G/A
- Filer
- Cytek Biosciences, Inc.
- CIK
- CIK 1831915
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership